Listing Follows Completion of Business
Combination with GS Acquisition Holdings Corp II
Mirion to Ring Closing Bell at the New York
Stock Exchange Today, October 21, 2021 at 4:00 PM EDT
Mirion Technologies, Inc. (“Mirion”) (NYSE:
MIR), a leading provider of detection, measurement, analysis and
monitoring solutions to the nuclear, defense, medical and research
end markets, announced that its Class A common stock and warrants
will begin trading on the New York Stock Exchange today under the
symbols “MIR” and “MIRW,” respectively. Management will participate
in a closing bell ceremony at the New York Stock Exchange today,
October 21, 2021, in celebration of the public listing.
“We are thrilled to embark upon our next chapter as a public
company and to continue to lead the market in radiation solutions
and services,” commented Thomas Logan, Chief Executive Officer of
Mirion. “This transaction allows us to continue to execute on our
strategic growth plans by expanding our product suite across the
industrial technology and medical segments and further executing on
our robust acquisition pipeline. We are also very pleased to
welcome Larry Kingsley to our Board as Chairman, who brings with
him a proven track record of operational success and driving value
creation for shareholders. I would like to thank the entire Mirion
team, as well as our partners Larry and Goldman Sachs, for their
support throughout this process, and we look forward to entering
this next phase for our business together.”
Larry Kingsley, former CEO of Pall Corporation and IDEX
Corporation, will assume the role of Chairman of the Company.
Mirion will continue to be led by 20-year industry veteran and
company founder, Mr. Logan.
Larry Kingsley, Chairman of Mirion, said, “I am very pleased to
be joining Tom and the Mirion team, who have done an excellent job
building a global company in good industries, with strong margin
profiles and robust free cash flow generation. There is ample room
ahead to drive margin expansion, execute on organic growth
opportunities, and drive long-term shareholder value.”
Prior to the closing of the business combination, Mirion was
majority owned by Charterhouse Capital Partners LLP
(“Charterhouse”), one of the longest established private equity
firms operating in Europe, which first invested in Mirion in
2015.
Chris Warren, Partner at Charterhouse, remarked, “Mirion’s
robust growth in recent years is a testament to the dedication of
the whole Mirion team. Having become the global leader in nuclear
measurement and following its strategic expansion into medical and
life sciences, Mirion is well positioned to capitalise on a wide
range of additional growth opportunities. We look forward to seeing
Mirion’s continued development and further accomplishments in years
to come and wish Tom and his team the best of luck.”
Mirion is a global provider of products, services, and software
that allows customers to safely leverage the power of ionizing
radiation through critical applications in the medical, nuclear and
defense markets, as well as laboratories, scientific research,
analysis and exploration. Mirion generated $612 million in revenue
for the fiscal year ended June 30, 2021, up 27.9% from the
prior-year period, reflecting core industrial market growth and the
continued success of key new product introductions in the medical
field.
Goldman Sachs & Co. LLC acted as lead placement agent and
exclusive financial advisor to GS Acquisition Holdings Corp II
(“GSAH”). Lazard Ltd. and HSBC acted as financial advisors to
Charterhouse and Mirion. Goldman Sachs Lending Partners LLC,
Citigroup Global Markets Inc., Jefferies Finance LLC and JPMorgan
Chase Bank, N.A. acted as joint lead arrangers and joint
bookrunners for the debt financing in support of the transaction.
Weil, Gotshal & Manges LLP acted as legal advisor to GSAH.
Davis Polk & Wardwell LLP acted as legal advisor to Mirion and
Freshfields Bruckhaus Deringer LLP acted as legal advisor to
Charterhouse. Sullivan & Cromwell LLP acted as legal advisor to
Goldman Sachs & Co. LLC as lead placement agent. Milbank LLP
acted as legal advisor to Goldman Sachs Lending Partners LLC and
Citigroup Global Markets Inc.
About Mirion Mirion Technologies is a leading provider of
detection, measurement, analysis and monitoring solutions to the
nuclear, defense, medical and research end markets. The
organization aims to harness its unrivaled knowledge of ionizing
radiation for the greater good of humanity. Many of the company's
end markets are characterized by the need to meet rigorous
regulatory standards, design qualifications and operating
requirements. Headquartered in Atlanta (GA – USA), Mirion employs
around 2,500 people and operates in 13 countries. For more
information, and for the latest news and content from Mirion, visit
Mirion.com. Prior to the closing of the business combination,
Mirion was majority owned by Charterhouse Capital Partners LLP.
About GSAH GS Acquisition Holdings Corp II (NYSE: GSAH)
is a special purpose acquisition company formed for the purpose of
effecting a merger, stock purchase or similar business combination
with one or more businesses. The company is sponsored by an
affiliate of The Goldman Sachs Group, Inc. In June 2020, GSAH
completed its initial public offering, raising $750 million from
investors.
Forward-Looking Statements This press release contains
“forward-looking statements” within the meaning of The Private
Securities Litigation Reform Act of 1995. Forward-looking
statements include, without limitation, statements regarding
trading of Mirion’s securities on the New York Stock Exchange,
Mirion’s market leadership and the ability of Mirion to drive
margin expansion and long-term shareholder value, execute on its
growth plans and expand its product suite, and potential
acquisitions. Such statements can be identified by the fact that
they do not relate strictly to historical or current facts. When
used in this press release, words such as “pro forma,”
“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“intend,” “may,” “might,” “plan,” “possible,” “potential,”
“predict,” “project,” “should,” “strive,” “would” and similar
expressions may identify forward-looking statements, but the
absence of these words does not mean that a statement is not
forward-looking. When Mirion discusses its strategies or plans, it
is making projections, forecasts and forward-looking statements.
Such statements are based on the beliefs of, as well as assumptions
made by and information currently available to Mirion’s
management.
These forward-looking statements involve significant risk and
uncertainties that could cause the actual results to differ
materially from the expected results. Most of these factors are
outside Mirion’s control and are difficult to predict. Factors that
may cause such differences include, but are not limited to: (1) the
ability to maintain the listing of Mirion’s securities on the New
York Stock Exchange; (2) the ability to recognize the anticipated
benefits of the business combination, which may be affected by,
among other things, competition, the ability of the combined
company to grow and manage growth profitably, maintain
relationships with customers and suppliers and retain its
management and key employees; (3) costs related to the business
combination; (4) changes in applicable laws or regulations; (5) the
possibility that Mirion may be adversely affected by other
economic, business, and/or competitive factors; (6) the outcome of
any legal proceedings that have been or may in the future be
instituted against Mirion or any of their respective directors or
officers; (7) the failure to realize anticipated pro forma results
or projections and underlying assumptions; (8) future global,
regional or local political, market and social conditions,
including due to the COVID-19 pandemic; and (9) other risks and
uncertainties indicated from time to time in the definitive proxy
statement/prospectus of Mirion, including those under “Risk
Factors” therein, and other documents filed or to be filed with the
Securities and Exchange Commission (“SEC”) by Mirion.
Forward-looking statements included in this release speak only
as of the date of this release. Mirion does not undertake any
obligation to update its forward-looking statements to reflect
events or circumstances after the date of this release. Additional
risks and uncertainties are identified and discussed in Mirion’s
reports filed with the SEC and available at the SEC’s website at
http://www.sec.gov.
Disclaimer This document does not constitute an offer to
sell or exchange, or the solicitation of an offer to buy or
exchange, any securities, nor shall there be any sale of securities
in any jurisdiction in which such offer, sale or exchange would be
unlawful prior to registration or qualification under the
securities laws of any such jurisdiction.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211021005376/en/
For investor inquiries: Brian Schopfer ir@mirion.com
For media inquiries: Phil Denning / Nora Flaherty E
MirionPR@icrinc.com
Patrick Scanlan Goldman Sachs & Co. LLC T +1
212-902-6164
GS Acquisition Holdings ... (NYSE:GSAH)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
GS Acquisition Holdings ... (NYSE:GSAH)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024